ConTiPi Medical

Noninvasive, Disposable Vaginal Devices for Pelvic Floor Disorders

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2014 by Elan Ziv, ConTiPi Medical operates with 1-10 employees. The company has secured funding across two rounds from five investors, including Capital Point. In June 2023, ConTiPi Medical raised $40 million in structured capital from Capital IP Investment Partners and Ghost Tree Partners.

Business overview

ConTiPi Medical develops noninvasive and disposable vaginal devices designed to address pelvic floor disorders in women, such as stress urinary incontinence and pelvic organ prolapse. Their core technology involves devices that are inserted vaginally using a disposable applicator, then expand to provide support to specific vaginal walls, and collapse for easy removal. The company serves the women's health market, offering products like Poise Impressa (for stress urinary incontinence, sold to Kimberly Clark Worldwide Inc.) and ProVate, a ring pessary solution for pelvic organ prolapse. ConTiPi Medical operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

In May 2023, ConTiPi Medical expanded its partnership with Indegene to commercialize the ProVate device. This development signals a strategic focus on market penetration and distribution for its key product, indicating a move towards broader accessibility and adoption of its innovative solutions for pelvic organ prolapse.

Company Intelligence Q&A

What was a significant funding event for ConTiPi Medical?
In June 2023, ConTiPi Medical raised $40 million in structured capital from Capital IP Investment Partners and Ghost Tree Partners.
Which product received FDA approval for ConTiPi Medical?
In July 2019, ConTiPi Medical received FDA approval for the marketing of a unique product for the treatment of pelvic organ prolapse in women.
What was the nature of the partnership between ConTiPi Medical and Indegene in 2021?
In March 2021, Indegene and ConTiPi Medical Ltd partnered to bring an innovative disposable non-surgical device to market to help women suffering from Pelvic Organ Prolapse (POP).
When did ConTiPi Medical launch its new website?
In May 2018, ConTiPi Medical launched a new website highlighting nonsurgical devices for pelvic floor disorders.
What was the outcome of the partnership expansion between Indegene and ConTiPi Medical in 2023?
In May 2023, Indegene and ConTiPi Medical expanded their partnership to commercialize the ProVate device.

External links